From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology.

Fiche publication

Date publication

juin 2025

Journal

Expert review of molecular diagnostics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BIBEAU Frédéric

Tous les auteurs :
Stenzinger A, Normanno N, Lamarca A, Rimassa L, Bibeau F, Taniere P, Vogel A, Hollebecque A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40574643

Résumé

Biliary tract cancer (BTC) comprises a group of aggressive malignancies with poor prognosis and limited therapeutic options. Next-generation sequencing (NGS) has advanced BTC management by identifying targetable genomic alterations. However, routine multigene NGS testing faces clinical, logistical, and economic barriers to widespread implementation.